The introduction of a cap on research and development (R&D) tax relief at three times the total of the companyʼs PAYE and NICs liability for that year is set to come into force in 2020 and could hit companies with a high R&D spend and low staff costs, despite protective measures, explains Stephen Relf ACA CTA
Already subscribed? Please log in.
Your free features:
- Breaking news and expert analysis
- Customisable daily newsletters
- Six free CPD learning modules each year
- Personalised CPD tracker
- Top 75 Firms league tables
- Regulatory changes
- Hardman’s Tax Data